| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/15/2009 | EP1437140B1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 04/15/2009 | EP1406599B1 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin |
| 04/15/2009 | EP1267634B1 Digestable chewing gum |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP1212446B1 Viral replicons and viruses dependent on inducing agents |
| 04/15/2009 | EP1161452B1 Covalently bridged insulin dimers |
| 04/15/2009 | EP1003474B1 Method of treating dry eye disease with purinergic receptor agonists |
| 04/15/2009 | CN101410127A Intraorally rapidly disintegrating tablet |
| 04/15/2009 | CN101410120A 抗炎的膦酸酯化合物 Phosphonate compound anti-inflammatory |
| 04/15/2009 | CN101410103A 固体药物制剂 The solid pharmaceutical preparation |
| 04/15/2009 | CN101410091A Drug delivery system for sustained delivery of glipizide |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN101407624A Thickener composition and method for thickening aqueous system |
| 04/15/2009 | CN101406704A Novel plant capsule film material and method for producing the same |
| 04/15/2009 | CN101406703A Transdermal analgesic systems with reduced abuse potential |
| 04/15/2009 | CN101406692A Vaccine composition containing transforming growth factor alpha |
| 04/15/2009 | CN101406691A Melittin complex nanometer granule for oral dosing and preparation method thereof |
| 04/15/2009 | CN101406678A Medicament for preventing and treating influenza of domestic bird |
| 04/15/2009 | CN101406676A Soft capsule for treating fatty liver and preparation method thereof |
| 04/15/2009 | CN101406660A Medicament for improving organism immunity of aquatic livestock |
| 04/15/2009 | CN101406648A Powder for destroying parasites and relieving itching containing Radix stemonae, pepper and Sophora flavescens |
| 04/15/2009 | CN101406607A Antibiotic and antiphlogistic medicine for preventing and treating bacteriosis of aquatic livestock |
| 04/15/2009 | CN101406565A Pepper Babu plaster for rheumatism and method for producing the same |
| 04/15/2009 | CN101406526A Compound scutellaria microemulsion formulation and preparation method thereof |
| 04/15/2009 | CN101406524A Vaginal lotion for cleaning, disinfecting and preventing diseases |
| 04/15/2009 | CN101406515A Breast perfusate for treating mammitis of milk cattle and preparation thereof |
| 04/15/2009 | CN101406502A Pain-dispelling powder (paste) containing clam extract as well as preparation method and application thereof |
| 04/15/2009 | CN101406493A Microsphere for injection of Cordyceps sinensis and preparation method thereof |
| 04/15/2009 | CN101406474A Nalmefene injection and preparation method thereof |
| 04/15/2009 | CN101406460A Euthyrox tablet |
| 04/15/2009 | CN101406458A Biodegradable polyester medicine-carrying microsphere of mimetic peroxidase and preparation method |
| 04/15/2009 | CN101406457A Process for the manufacture of a pharmaceutical product |
| 04/15/2009 | CN101406455A Strychnine composite phospholipid liposome, and preparation method thereof and use in pharmacy |
| 04/15/2009 | CN101406454A Low molecular weight chitosan modified liposomes and preparation method thereof |
| 04/15/2009 | CN101406453A Pharmaceutical compositions for oral and topical administration |
| 04/15/2009 | CN101406440A Cosmetics or medicament preparing article |
| 04/15/2009 | CN100478380C Chemical preparation method of hollow polymer microsphere with controllable open pores |
| 04/15/2009 | CN100478359C Polyethylene glycol-interferon coupler and its preparation method |
| 04/15/2009 | CN100478032C Preparation method of injection type pH and glucose sensitive hydrogel |
| 04/15/2009 | CN100478030C SARS resisting medicine action target and its preventing and treating medicine |
| 04/15/2009 | CN100478026C Delivery system for biological component |
| 04/15/2009 | CN100477998C Instant pyrobixi freeze-drying powdery injection and its production |
| 04/15/2009 | CN100477997C Hydrophobic formulation containing total notoginseng glycosides and phospholipid and preparation method thereof |
| 04/15/2009 | CN100477986C Ascending-dose dosage form |
| 04/14/2009 | US7517983 Hydrazines and derivatives production process from hydrazines and dicarboxylic acid |
| 04/14/2009 | US7517974 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 04/14/2009 | US7517963 Tumour necrosis factor binding ligands |
| 04/14/2009 | US7517953 With low peroxide and anisidine values and high polyunsaturated fatty acid content; heating from 40 to 70 degrees C at a rate of 1 degree per minute, a plateau stage, cooling at the same rate; improved electrical efficency; baby formula |
| 04/14/2009 | US7517914 Controlled degradation materials for therapeutic agent delivery |
| 04/14/2009 | US7517913 ribozyme ribonuclease P, interleukin-2 and interferon- gamma inhibitors; for neoplastic, keratinization and inflammatory disorders; N1,N12-Bisretinoylspermine; condensation of polyamines or suitably protected derivatives with vitamin A derivatives |
| 04/14/2009 | US7517862 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517855 Peptides which inhibit angiogenesis, cell migration, cell invasion and cell proliferation, compositions and uses thereof |
| 04/14/2009 | US7517587 Lipids; sonication; dialysis; encapsulation; for use as membrane protein vector or molecular motor |
| 04/14/2009 | US7517539 Method of preparing a poorly crystalline calcium phosphate and methods of its use |
| 04/14/2009 | US7517537 Process for decontaminating a fluid |
| 04/14/2009 | US7517527 Immunotoxin with in vivo T cell suppressant activity and methods of use |
| 04/14/2009 | CA2474988C Polymeric matrices and their uses in pharmaceutical compositions |
| 04/14/2009 | CA2445506C Use of sucralfate for the treatment of cervical erosion |
| 04/14/2009 | CA2348871C Multiparticulate modified release composition |
| 04/14/2009 | CA2336570C Croscarmellose taste masking |
| 04/14/2009 | CA2335900C Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 04/14/2009 | CA2318576C Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 04/14/2009 | CA2275858C Vitamin powders for beverage applications |
| 04/14/2009 | CA2269682C Improved pharmaceutical compositions |
| 04/14/2009 | CA2234231C Stabilizing formulation for ngf |
| 04/14/2009 | CA2232378C Aerosol compositions |
| 04/14/2009 | CA2229351C Free-flowing dried particles |
| 04/14/2009 | CA2227891C Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 04/14/2009 | CA2204493C Application of superoxide dismutase in liposomes |
| 04/14/2009 | CA2166204C Pharmaceutical compositions for sparingly soluble therapeutic agents |
| 04/14/2009 | CA2139757C Liposomes, method of preparing the same and use thereof in the preparation of drugs |
| 04/09/2009 | WO2009046446A2 Dendrimers for sustained release of compounds |
| 04/09/2009 | WO2009046294A2 Treatment of proliferative disorders using antibodies to psma |
| 04/09/2009 | WO2009046281A2 Injectable particles |
| 04/09/2009 | WO2009046220A2 Lipopeptides for delivery of nucleic acids |
| 04/09/2009 | WO2009045539A2 Peg-corticosteroid conjugates |
| 04/09/2009 | WO2009045457A2 Tripartite rnai constructs |
| 04/09/2009 | WO2009044918A1 Neuromedin u derivative |
| 04/09/2009 | WO2009044895A1 Composition inhibiting the expression of target gene |
| 04/09/2009 | WO2009044854A1 Granule, tablet, and their production methods |
| 04/09/2009 | WO2009044694A1 Method of producing emulsion or dispersion and food, skin external preparation and drug containing emulsion or dispersion obtained by the production method |
| 04/09/2009 | WO2009044410A1 Intrinscially fluorescent carbon nanospheres and a process thereof |
| 04/09/2009 | WO2009043988A2 Method for producing stable powder compositions |
| 04/09/2009 | WO2009043926A2 Oral fast disintegrating tablets |
| 04/09/2009 | WO2009043899A1 Drug transfer into living cells |
| 04/09/2009 | WO2009043879A1 Composition for controlling lipase catalyzed reactions |
| 04/09/2009 | WO2009043226A1 A stable liquid composition comprising taxan derivatives and its preparation method. |
| 04/09/2009 | WO2009043184A1 Nucleotide modular assemblies and their use as delivery devices |
| 04/09/2009 | WO2009043174A1 Oligofluorinated cross-linked polymers and uses thereof |
| 04/09/2009 | WO2009043166A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/09/2009 | WO2009043165A1 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| 04/09/2009 | WO2009012785A3 Complexes of an emulgator and a fatty acid |
| 04/09/2009 | WO2009012784A3 Methods for preparing cytotoxic complexes of emulsifier and fatty acid |
| 04/09/2009 | WO2009007137A3 Pharmaceutical composition for topical application of poorly soluble compounds |
| 04/09/2009 | WO2009004999A8 Seamless capsule |
| 04/09/2009 | WO2008137758A3 Amino acid lipids and uses thereof |
| 04/09/2009 | WO2008112124A3 Orally administrable films |
| 04/09/2009 | WO2008095586A3 Aqueous composition comprising chitosan and an acidic drug |
| 04/09/2009 | WO2008082669A3 Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage |